Welcome to our dedicated page for Amphenol SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amphenol Corporation (NYSE: APH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Amphenol uses Form 8-K current reports extensively to announce material events, including acquisitions, financing arrangements and governance changes.
Recent APH filings include Form 8-K reports detailing the completion of the acquisition of CommScope’s Connectivity and Cable Solutions business for approximately $10.5 billion in cash, the entry into three-year and 364-day unsecured delayed draw term loan credit agreements intended to help finance that acquisition, and the issuance of multiple series of senior notes with maturities ranging from 2027 to 2055. Other 8-Ks cover topics such as quarterly financial results, the acquisition of Trexon, the acquisition of Rochester Sensors, and the appointment of Sanjiv Lamba to Amphenol’s board of directors.
On this page, you can review Amphenol’s current reports on Form 8-K, as well as its annual reports on Form 10-K, quarterly reports on Form 10-Q and other registered securities documents when available. These filings provide insight into Amphenol’s interconnect, sensor and cable businesses, its capital structure, and its acquisition and financing strategies.
Stock Titan enhances these documents with AI-powered summaries that highlight key terms, such as acquisition consideration, financing amounts, segment classification for acquired businesses, and significant changes in governance or capital markets activity. Users can also quickly locate information about Amphenol’s registered securities, including its Class A common stock and listed senior notes, and monitor new filings as they are posted to EDGAR.
For investors analyzing APH stock, this filings page offers a structured way to review Amphenol’s regulatory history, understand the details behind major transactions like the CCS acquisition and Trexon purchase, and see how the company discloses risks, non-GAAP measures and other important information in its SEC reports.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 100,000 common shares by a person who acquired those shares via exercise of options under a registered plan on 08/18/2025. The filing shows the sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $11,060,030.00 and a reported outstanding share count of 1,220,921,111. The filer states no securities were sold by the same person in the past three months and certifies lack of undisclosed material adverse information.
Amphenol Corp (APH) insider William J. Doherty, President of the CS Division, reported option exercises and immediate sales of Class A common stock. The form shows exercises of stock options with an exercise price of $22.5525 that were converted into 113,000 shares on 08/08/2025 and again on 08/11/2025, with the options listed as exercisable since 05/21/2021 and expiring 05/21/2030.
On each date the acquired shares were sold: the 08/08/2025 sale reported a weighted-average price of $108.8916 (trades ranged $108.7550–$109.1900) and the 08/11/2025 sale reported a weighted-average price of $110.2906 (trades ranged $110.00–$110.9100). After the reported sales the filing shows 0 shares held by the reporting person. The form is signed by a POA, Lance E. D'Amico.
Michael R. Ivas, Amphenol Corporation's VP & Corporate Controller, reported an option exercise and an immediate sale of the resulting shares on 08/08/2025. He exercised 50,000 stock options at an exercise price of $18.23 and acquired 50,000 Class A shares, then sold 50,000 Class A shares at a weighted average sale price of $110.0164 (executed in multiple trades between $110.00 and $110.08). After these transactions the filing shows 152,412 shares beneficially owned directly by the reporting person and 0 stock options remaining. The filing also lists indirect holdings of 2,995 shares by children and 1,700 shares by spouse. The report documents conversion/exercise activity and a contemporaneous sale, reducing derivative holdings to zero while leaving a material direct ownership stake.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed Rule 144 sale of 113,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $12,462,837.80 and 1,220,921,111 shares outstanding. The filing shows these shares were acquired on 08/11/2025 by exercise of options under a registered plan and payment was made in cash on the same date.
The filing also lists recent sales by the named seller, William Doherty: 113,000 shares sold on 08/08/2025 for $12,304,750.80 and 160,000 shares sold on 05/30/2025 for $14,326,512.00, totaling 273,000 shares and $26,631,262.80 in gross proceeds during the past three months. The notice includes the seller's representation that no undisclosed material adverse information exists.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $5,500,820.00. The filing states the company has 1,220,921,111 shares outstanding and lists the approximate date of sale as 08/08/2025. The shares were reported acquired the same day by exercise of options under a registered plan and paid for in cash. The notice also discloses a prior sale of 40,000 shares on 05/29/2025 for gross proceeds of $3,551,408.00. The filer affirms they do not possess undisclosed material adverse information.
Amphenol Corporation (APH) Form 144 notice reports a proposed sale of 113,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $12,304,750.80 and an approximate sale date of 08/08/2025. The shares were acquired on 08/08/2025 by exercising options under a registered plan and were to be paid in cash. The filing records total shares outstanding of 1,220,921,111 for the issuer. The document also discloses a prior sale of 160,000 shares on 05/30/2025 that generated gross proceeds of $14,326,512.00. The seller affirms no knowledge of undisclosed material adverse information.